
Cetroript TZ 250mg/31.25mg Injection
Marketer
Kript Pharmaceuticals Private Limited
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Cetroript TZ 250mg/31.25mg Injection
Cefixime and Azithromycin injection, 250mg/31.25mg, is a dual-action antibiotic used to combat diverse bacterial infections. Its mechanism involves inhibiting bacterial growth and propagation. Administration must be solely under medical guidance. Adherence to the prescribed dosage schedule is crucial; completing the full course is essential, even with symptom improvement, as premature cessation may reduce efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening symptoms require immediate medical attention. Seek immediate medical assistance for allergic reactions (rash, pruritus, edema, dyspnea). Inform your physician of all current medications, including those for pre-existing conditions. Pregnant or lactating individuals require prior consultation. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, avoid driving if drowsiness or dizziness occurs. Adequate rest, nutrition, and hydration are recommended for optimal recovery. Your doctor may order laboratory tests to monitor treatment response.
Primary Ingredients of Cetroript TZ 250mg/31.25mg Injection
No information provided. Please provide the text you wish me to rewrite.
Uses of Cetroript TZ 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Cetroript TZ 250mg/31.25mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Cetroript TZ 250mg/31.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Cetroript TZ 250mg/31.25mg Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
How Cetroript TZ 250mg/31.25mg Injection works:
Ceftriaxone and Tazobactum, combined as Cetroript TZ 250mg/31.25mg Injection, offer a dual-action approach to bacterial infection. Ceftriaxone's antibiotic properties disrupt bacterial cell wall synthesis, hindering their ability to thrive. The beta-lactamase inhibitor, Tazobactum, counters bacterial resistance mechanisms, thus amplifying Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Concurrent use of alcohol and Cetroript TZ 250mg/31.25mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Cetroript TZ 250mg/31.25mg is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, data from human studies remain scarce.
Breast feedingCAUTION
Administering Cetroript TZ 250mg/31.25mg Injection to breastfeeding mothers requires careful consideration. Discontinue breastfeeding throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administration of Cetroript TZ 250mg/31.25mg Injection can induce drowsiness, blurred vision, and dizziness. Refrain from operating a vehicle if experiencing these effects.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Cetroript TZ 250mg/31.25mg Injection to individuals with impaired renal function. Physician consultation is advised.
LiverCAUTION
Exercise caution when administering Cetroript TZ 250mg/31.25mg Injection to individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician before administering. Dosage changes for Cetroript TZ 250mg/31.25mg Injection are not advised for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Cetroript TZ 250mg/31.25mg Injection :
Should you forget a scheduled dose of Cetroript TZ 250mg/31.25mg Injection, seek medical advice.
Facts to Know About Cetroript TZ 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Antimicrobial Agents |
